in conjunction with

The 11th International Symposium on Hypertension and Related Diseases

and celebrating the

World Hypertension League 25th AnniversaryChinese Hypertension League 20th Anniversary

Organized by Co-organized by

World Hypertension League Chinese Hypertension League

www.worldhypertension2009.com

Hypertension Management — From Bench To Bedside And Community

WHC 2009 Highlights2009 is a milestone for both the World Hypertension League (WHL) and the Chinese Hypertension League (CHL). This year, as a world organization dedicated to hypertension prevention and control, the WHL will celebrate its 25th anniversary. In the same year, the CHL, the sole representative of the WHL in China, will celebrate its 20th anniversary.

In celebration of this meaningful achievement, the WHL in conjunction with the CHL will organize the World Hypertension Congress 2009, an international gathering bringing together global experts to present and discuss clinical and public health topics in the area of hypertension and cardiovascular disease prevention and management.

This four-day conference (October 29 ~ November 1, 2009, Beijing) has as its focus Hypertension Management—From Bench to Bedside and Community. It will provide an opportunity to look back with pride on the advances achieved in hypertension and cardiovascular disease management, and more importantly, to look ahead at the great challenges we are facing right now and those we will be facing in the future. How do we apply what we know now and bring it from the research bench to the bedside and the community?

Who will Attend?This important event will be of interest not only to clinical physicians and research scientists but also healthcare professionals, community healthcare workers and industry representatives. Delegates from over 85 member countries are expected to attend.

We estimate that over 4000 delegates will join the congress. Over 30% of delegates are expected to be from countries outside China, and the majority of these delegates will be from countries in the APAC region.

ProgramThe 3.5 day program will concentrate on diagnosis and treatment, primary and secondary prevention, improving the application of preventative care in a continuous way on a patient-to-patient basis.

Hot topics include:

The program will be presented in the following formats:

Keynote Presentations

Lectures

Oral Presentations/Poster Presentations

Community Forums

Meet the Experts

Debates

Case Discussions

Late-breaking Studies

Industry- and Investigator-initiated Symposia

Exhibitions

Pre-hypertension

Salt and Hypertension

Ethnic and Regional Differences in Hypertension

Ten-year Risk? Lifetime Risk?

RAS Blockade

Hypertension and Atrial Fibrillation

Hypertension and the Kidney

Metabolic Syndrome

Clinical Trials: How to Translate into Practice

Translational Medicine

BPMD

Blood Vessels

Endothelium

Dementia

Pharmacogenetics

Hypertension and Traditional Chinese Medicine

International Guidelines and Local

Recommendations

Worksite Blood Pressure Management

Hypertension Excellence Center

Community Management Experience Sharing

Participation of Worldwide Authorities in HypertensionAlthough it is still too early to disclose the speaker list, we are glad to announce that we have secured a number of highly respected international speakers to be our Organizing and Scientific Committee members. They are:

No Name Title Organization Country

1 Lisheng Liu President World Hypertension League China

2 Detlev Ganten MD, PhD, Chairman Charité Foundation Germany

3 Lenfant Claude Distinguished Scientist Emeritus National Institutes of Health USA

4 Peter Sleight Professor Dept of Cardiovascular Medicine Oxford UK

5 Lawrence J. Beilin Professor, Honorary Consultant Royal Perth Hospital Australia

6 Arun Chockalingam Professor Simon Fraser University Canada

7 Joerg Poetzsch PhD, WHL Advisor World Hypertension League Germany

8 J. George Fodor Professor Minto Prevention and Rehabilitation Centre University of Ottawa Heart Institute

Canada

9 Graham MacGregor Professor St George’s University of London UK

10 Alfredo Duenas Professor, MD Institute of Cardiology and Cardiovascular Surgery of Havana Cuba

11 Shanthi Mendis Prof, MD Departments of Neurology and Epidemiology, University of California USA

12 Trefor Morgan Professor University of Melbourne Australia

13 Anthony M. Heagerty Professor University of Manchester USA

14 Tsuyoshi Fujita Professor Osaka University Graduate School of Medicine Japan

15 Ernesto L. Schiffrin MD, PhD Sir Mortimer B. Davis-Jewish General Hospital Canada

16 Lars Hjalmar Lindholm Professor Umeå University Hospital Sweden

17 Robert Fagard Prof, MD, PhD Katholieke Universiteit Leuven Belgium

18 John E. Hall PhD University of Mississippi Medical Center USA

19 Rhian M. Touyz Professor, MD, PhD Ottawa Health Research Institute, University of Ottawa Canada

20 Terrence E. Forrester Prof, MD, PhD University of the West Indies India

21 Guido Grassi Professor University of Milano Bicocca Italy

22 Osvaldo J Kohlmann MD, PhD, Associate Professor Kidney and Hypertension Hospital Brazil

23 Gérard M. London Professor Centre Hospitalier Manhès France

24 Basden J.C. Onwubere Professor University of Nigeria Teaching Hospital Nigeria

25 Suzanne Oparil Professor, MD University of Alabama USA

26 Kazuaki Shimamoto Professor, MD, PhD Sapporo Medical University Japan

27 Naftali Stern Professor, Director Institute of Endocrinology, Metabolism and Hypertension Tel Aviv-Sourasky Medical Center

Israel

28 Mohd Kamil Yusoff Professor Universiti Teknologi MARA Japan

29 John Chalmers Senior Director The George Institute for International Health Australia

30 Paul Landsbergis PhD, MPH State University of New York-Downstate Medical Center USA

31 Alberto Zanchetti Professor Italian Institute for Auxology Italy

32 Giuseppe Mancia Professor University of Milano-Bicocca Italy

33 Michael H. Alderman Professor Albert Einstein College of Medicine USA

34 Kikuo Arakawa Professor, President Japanese Association of Hypertension Japan

35 Lip Ping Low Professor University of Singapore Singapore

36 Masatsugu Horiuchi Prof, MD, PhD Department of Molecular Cardiovascular Biology and Pharmacology Ehime University, Graduate School of Medicine Tohon

Japan

37 Yutaka Imai Professor Tohoku University Graduate School of Pharmaceutical Sciences and Medicine Japan

38 Toshio Ogihara Professor Osaka University Japan

39 Jan Staessen Prof, MD, PhD Laboratory of Hypertension, Campus Gasthuisberg Belgium

40 Gianfranco Parati Director Dept of Cardiology, S.Luca Hospital Italy

41 Eoin O’Brien Professor, President Irish Heart Foundation Ireland

42 Neil Poulter Professor Imperial College London United Kingdom

43 Peter Meredith Phd, Faculty of Medicine University of Glasgow

44 Bryan Williams Professor, MD University of Leicester School of Medicine UK

45 Stevo Julius Professor, MD, ScD University of Michigan Cardiovascular Center USA

46 Harry Black President, MD, MACP American Society of Hypertension USA

47 Michael O’Rourke MD, DSc, FACC St. Vincent’s Hospital/University of New South Wales Australia

48 John E. Sanderson Professor University of Birmingham UK

49 Hakon Hakonarson Prof, MD, PhD, Director Center for Applied Genomics, The Joseph Stokes Jr. Research Institute Philadelphia

50 Christopher J. Bulpitt Professor Hammersmith Hospital UK

Societies of Endorsement

A wide range of international, regional and country societies have committed to provide strong support to

WHC 2009, and more will join as supporting societies in the coming months, which will ensure the success

of delegate recruitment and abstract submission. As of April 12, the supporting societies are as follows:

International Society of Hypertension (ISH)

European Society of Hypertension (ESH)

American Society of Hypertension (ASH)

International Society of Nephrology (ISN)

American College of Cardiology (ACC)

Blood Pressure Canada (BPC)

Asian Pacific Society of Cardiology (APSC)

The Asian Pacific Society of Nephrology (APSN)

Italian Society and League of Hypertension (ISLH)

Japanese Society of Hypertension (JSH)

Japanese Society of Nephrology (JSN)

Taiwan Society of Nephrology (TSN)

Malaysian Society of Nephrology (MSN)

Cameroon Heart Foundation (CHF)

Egyptian Hypertension Society (EHS)

Israel Hypertension Society (IHS)

High Blood Pressure Research Council of Australia (HBPRCA)

Diabetes Hong Kong

Hong Kong Society of Nephrology (HKSN)

All India Heart Foundation (AIHF)

Lebanese Hypertension League (LHL)

Nigerian Hypertension Society (NHS)

Saudi Hypertension Management Society (SHMS)

Slovak League Against Hypertension (SLAH)

Australian and New Zealand Society of Nephrology (ANZSN)

Hypertension Committee of the National Heart Foundation of Bangladesh (HCNHFB)

Turkish Society of Hypertension and Kidney Disease (TSHKD)

Stroke Society of Australasia (SSA)

Serbian Hypertension Society (SHS)